Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/116616 |
Resumo: | Group A rotavirus (RVA) remains the most important etiological agent associated with severe acute diarrhea in children. Rotarix® monovalent vaccine was introduced into Mozambique’s Expanded Program on Immunization in September 2015. In the present study, we report the diversity and prevalence of rotavirus genotypes, pre-(2012–2015) and post-vaccine (2016–2019) introduction in Mozambique, among diarrheic children less than five years of age. Genotyping data were analyzed for five sentinel sites for the periods indicated. The primary sentinel site, Mavalane General Hospital (HGM), was analyzed for the period 2012–2019, and for all five sites (country-wide analyses), 2015–2019. During the pre-vaccine period, G9P[8] was the most predominant genotype for both HGM (28.5%) and the country-wide analysis (46.0%). However, in the post-vaccine period, G9P[8] was significantly reduced. Instead, G3P[8] was the most common genotype at HGM, while G1P[8] predominated country-wide. Genotypes G9P[4] and G9P[6] were detected for the first time, and the emergence of G3P[8] and G3P[4] genotypes were observed during the post-vaccine period. The distribution and prevalence of rotavirus genotypes were distinct in pre-and post-vaccination periods, while uncommon genotypes were also detected in the post-vaccine period. These observations support the need for continued country-wide surveillance to monitor changes in strain diversity, due to possible vaccine pressure, and consequently, the effect on vaccine effectiveness. |
id |
RCAP_5f52cdbcd6fd1611d3e9b33de306d52b |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/116616 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019emergence of genotypes G3P[4] and G3P[8]G3 genotypeMozambique vaccine surveillanceRotarixRotavirus type AImmunology and AllergyMolecular BiologyImmunology and Microbiology(all)Microbiology (medical)Infectious DiseasesSDG 3 - Good Health and Well-beingGroup A rotavirus (RVA) remains the most important etiological agent associated with severe acute diarrhea in children. Rotarix® monovalent vaccine was introduced into Mozambique’s Expanded Program on Immunization in September 2015. In the present study, we report the diversity and prevalence of rotavirus genotypes, pre-(2012–2015) and post-vaccine (2016–2019) introduction in Mozambique, among diarrheic children less than five years of age. Genotyping data were analyzed for five sentinel sites for the periods indicated. The primary sentinel site, Mavalane General Hospital (HGM), was analyzed for the period 2012–2019, and for all five sites (country-wide analyses), 2015–2019. During the pre-vaccine period, G9P[8] was the most predominant genotype for both HGM (28.5%) and the country-wide analysis (46.0%). However, in the post-vaccine period, G9P[8] was significantly reduced. Instead, G3P[8] was the most common genotype at HGM, while G1P[8] predominated country-wide. Genotypes G9P[4] and G9P[6] were detected for the first time, and the emergence of G3P[8] and G3P[4] genotypes were observed during the post-vaccine period. The distribution and prevalence of rotavirus genotypes were distinct in pre-and post-vaccination periods, while uncommon genotypes were also detected in the post-vaccine period. These observations support the need for continued country-wide surveillance to monitor changes in strain diversity, due to possible vaccine pressure, and consequently, the effect on vaccine effectiveness.Instituto de Higiene e Medicina Tropical (IHMT)Global Health and Tropical Medicine (GHTM)Vector borne diseases and pathogens (VBD)RUNJoão, Eva D.Munlela, BenildeChissaque, AssucênioChilaúle, JorféliaLanga, JerónimoAugusto, OrvalhoBoene, Simone S.Anapakala, EldaSambo, JúliaGuimarães, EsperançaBero, DiocrecianoCassocera, MartaCossa-Moiane, IdaléciaMwenda, Jason M.Maurício, IsabelO’neill, Hester G.de Deus, Nilsa2021-05-01T22:51:42Z2020-08-192020-08-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article16application/pdfhttp://hdl.handle.net/10362/116616eng2076-0817PURE: 19930925https://doi.org/10.3390/pathogens9090671info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:59:16Zoai:run.unl.pt:10362/116616Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:43:10.202713Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 emergence of genotypes G3P[4] and G3P[8] |
title |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 |
spellingShingle |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 João, Eva D. G3 genotype Mozambique vaccine surveillance Rotarix Rotavirus type A Immunology and Allergy Molecular Biology Immunology and Microbiology(all) Microbiology (medical) Infectious Diseases SDG 3 - Good Health and Well-being |
title_short |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 |
title_full |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 |
title_fullStr |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 |
title_full_unstemmed |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 |
title_sort |
Molecular epidemiology of rotavirus a strains pre-and post-vaccine (Rotarix®) introduction in mozambique, 2012–2019 |
author |
João, Eva D. |
author_facet |
João, Eva D. Munlela, Benilde Chissaque, Assucênio Chilaúle, Jorfélia Langa, Jerónimo Augusto, Orvalho Boene, Simone S. Anapakala, Elda Sambo, Júlia Guimarães, Esperança Bero, Diocreciano Cassocera, Marta Cossa-Moiane, Idalécia Mwenda, Jason M. Maurício, Isabel O’neill, Hester G. de Deus, Nilsa |
author_role |
author |
author2 |
Munlela, Benilde Chissaque, Assucênio Chilaúle, Jorfélia Langa, Jerónimo Augusto, Orvalho Boene, Simone S. Anapakala, Elda Sambo, Júlia Guimarães, Esperança Bero, Diocreciano Cassocera, Marta Cossa-Moiane, Idalécia Mwenda, Jason M. Maurício, Isabel O’neill, Hester G. de Deus, Nilsa |
author2_role |
author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Instituto de Higiene e Medicina Tropical (IHMT) Global Health and Tropical Medicine (GHTM) Vector borne diseases and pathogens (VBD) RUN |
dc.contributor.author.fl_str_mv |
João, Eva D. Munlela, Benilde Chissaque, Assucênio Chilaúle, Jorfélia Langa, Jerónimo Augusto, Orvalho Boene, Simone S. Anapakala, Elda Sambo, Júlia Guimarães, Esperança Bero, Diocreciano Cassocera, Marta Cossa-Moiane, Idalécia Mwenda, Jason M. Maurício, Isabel O’neill, Hester G. de Deus, Nilsa |
dc.subject.por.fl_str_mv |
G3 genotype Mozambique vaccine surveillance Rotarix Rotavirus type A Immunology and Allergy Molecular Biology Immunology and Microbiology(all) Microbiology (medical) Infectious Diseases SDG 3 - Good Health and Well-being |
topic |
G3 genotype Mozambique vaccine surveillance Rotarix Rotavirus type A Immunology and Allergy Molecular Biology Immunology and Microbiology(all) Microbiology (medical) Infectious Diseases SDG 3 - Good Health and Well-being |
description |
Group A rotavirus (RVA) remains the most important etiological agent associated with severe acute diarrhea in children. Rotarix® monovalent vaccine was introduced into Mozambique’s Expanded Program on Immunization in September 2015. In the present study, we report the diversity and prevalence of rotavirus genotypes, pre-(2012–2015) and post-vaccine (2016–2019) introduction in Mozambique, among diarrheic children less than five years of age. Genotyping data were analyzed for five sentinel sites for the periods indicated. The primary sentinel site, Mavalane General Hospital (HGM), was analyzed for the period 2012–2019, and for all five sites (country-wide analyses), 2015–2019. During the pre-vaccine period, G9P[8] was the most predominant genotype for both HGM (28.5%) and the country-wide analysis (46.0%). However, in the post-vaccine period, G9P[8] was significantly reduced. Instead, G3P[8] was the most common genotype at HGM, while G1P[8] predominated country-wide. Genotypes G9P[4] and G9P[6] were detected for the first time, and the emergence of G3P[8] and G3P[4] genotypes were observed during the post-vaccine period. The distribution and prevalence of rotavirus genotypes were distinct in pre-and post-vaccination periods, while uncommon genotypes were also detected in the post-vaccine period. These observations support the need for continued country-wide surveillance to monitor changes in strain diversity, due to possible vaccine pressure, and consequently, the effect on vaccine effectiveness. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-08-19 2020-08-19T00:00:00Z 2021-05-01T22:51:42Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/116616 |
url |
http://hdl.handle.net/10362/116616 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2076-0817 PURE: 19930925 https://doi.org/10.3390/pathogens9090671 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
16 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138041900564480 |